The corpus callosum (Latin: 'tough body') is the human brain's largest white matter tract, and its largest commissure. 1, 2 The callosum was first named by Galen of Pergamum in ancient Rome, at the beginning of the first century AD, among a range of other central nervous system structures. Up until the 16th century, it was generally felt to be a supporting or 'scaffolding' structure only. In 1543, Andreas Vesalius described its anatomy for the first time, recognising that it linked the two halves of the brain and was continuous with the white matter of the hemispheres. In the 1600s, La Peyronie, Professor of Surgery at Montpellier, selected it as the 'seat of the soul', as it seemed to be the most interconnected of brain structures.
Our modern view of the corpus callosum recognises its crucial role in connecting the cerebral hemispheres. The callosum forms a high-bandwidth neural pathway between the two hemispheres, facilitating information transfer and unifying information that enters in a lateralised fashion into the hemispheric system. It contains in the region of 60 million axons, [3] [4] [5] fibres that mediate sensory-motor coordination, and connect equivalent association cortical regions across hemispheres. 6 The callosum has a critical role in attentional arousal, and the integration and communication of high-level motor, cognitive and sensory information. 7 Given that fibres from most cortical regions traverse the callosum, it is seen as an attractive structure to study as regional brain changes can be reflected in regional shape changes in the callosum.
Callosal morphology in schizophrenia
With the advent of modern neuroimaging techniques, the callosum became an attractive candidate for analysis via structural imaging: an obviously bright structure on sagittal images, it is readily segmented from surrounding structures; its unique shape profile lends itself to a range of morphological descriptors, such as area, thickness and curvature. Unlike other brain structures, the callosum does not lend itself to anatomically meaningful volume estimations because of the absence of clear lateral boundaries; researchers have thus relied on estimates of area or shape. Its topographical fibre organisation -where anterior segments connect anterior cortical regions and posterior segments connect posterior cortical regions 8 -suggests that regional cortical alterations may be detectable as subtle regional changes in callosal shape or thickness. In this way, the callosum potentially provides a window to cortical changes in brain disorders, and such changes have been of clinical utility in the differentiation of dementia subtypes. 9 The shape of other topographically organised and projecting structures, such as the basal ganglia, has similarly been shown to differentiate between subtypes of neurodegenerative disorders. 10 The first magnetic resonance imaging (MRI) study suggested alterations in corpus callosum size and shape. 11 Since this initial study, the widespread availability of MRI scanning has resulted in a range of studies examining the callosum from a variety of morphological perspectives, revealing a number of ways in which the callosum in people with schizophrenia appears to differ from healthy controls, and across different stages of illness ( Fig. 1 ).
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Two meta-analyses of these studies, almost 15 years apart, are consistent with the finding that the callosum is smaller in schizophrenia, 15, 16 although the latter meta-analysis suggests that this effect may be greatest in patients with first-episode schizophrenia. The difficulty in extracting the nature of the true signal regarding callosal morphology in schizophrenia across these studies is the significant variety of methodological approaches used (with manifold ways to account for head size, choose a consistent mid-sagittal image across participants and parcellate the callosum in anatomically meaningful ways), and the way that descriptors of the callosum are used in these studies: 'shape', 'size' and 'reduction' are terms that have different meanings according to the differences across methodological approaches and statistical models. This heterogeneity may thus dilute or alter the findings from meta-analyses that attempt to combine studies with varying methodology; thus large multistage cohorts who are examined across different phases of psychosis utilising the same sequence parameters and image analysis [12] [13] [14] psychosis and/or established illness, a true understanding of shape changes as described by any particular method would be applied across different stages of illness: pre-psychotic, first-episode and established illness. 12, 13 Additionally, volumetric imaging -from which callosal shape can be derived -is limited in its capacity to inform on microstructural changes within brain regions. Recent white matter imaging techniques such as diffusion tensor imaging (DTI) suggest that some of the callosal shape alterations in schizophrenia are driven by alterations to white matter microstructure, either through disrupted myelination or altered axonal structure or organisation. 17 Finally, although white and grey matter structures are arbitrarily separated based on their macrostructural appearance and intensity on T 1 -weighted MRI sequences, they remain different components of groups of the same functional unit: the neuron and its axonal process. When white matter change is seen in any illness, the interdependent nature of grey and white matter compartments means that change may be driven by a mixture of primary white matter pathology, or alterations that occur secondary to grey matter change. 18, 19 As a result, a true determination of the role of white matter change in any cohort of patients with schizophrenia will necessarily also analyse grey matter findings in the same cohort.
The study described by Collinson et al in this issue addresses some, albeit not all, of these issues within one large cohort of 120 patients (with first-episode and established schizophrenia) and 75 controls. 20 This study utilised both high-resolution volumetric T 1 -weighted images and diffusion-tensor images acquired in the same session on all participants. This welldesigned study has some compelling advantages: a large sample size recruited from one geographical region; patients at different illness stages; and an imaging protocol examining both volumetric and microstructural measures of the callosum. It showed that the differences were detectable only between patients with established schizophrenia and controls, but individuals with first-episode schizophrenia showed no significant difference. Additionally, the DTI measures, which could be expected to potentially underpin volumetric change, showed no difference on any group analysis. It adds to the heterogeneity of findings in patients with schizophrenia: the most recent structural imaging meta-analysis suggests that volumetric reductions may be greatest in first-episode rather than established illness, 16 and a meta-analysis of DTI findings suggests significant reductions in microstructural integrity of the splenium across studies. 21 The Collinson et al study also illustrates some of the potential pitfalls of studying any structure in schizophrenia, where the choice of methodology may have an impact on the capacity to detect change. One key example is in accounting for head size; many callosal studies have covaried for intracranial volume to account for this, although using a linear transformation and scaling has been shown to be superior in detecting true between-group differences;
22 transformation is part of the FreeSurfer pipeline used by Collinson and colleagues in their analysis. Furthermore, most studies of the callosum attempt to find local regional differences, thus moving from a pure area/ volume measure to a de facto metric of shape. Choice of shape metric and method may similarly affect the capacity to detect results, with sophisticated, sensitive and anatomically informed shape analysis methods for the callosum now being described. 23, 24 A move to these more sophisticated methods, combined with the microstructural methods as utilised in the Collinson et al study, are -at least in part -the way to move the field forward.
Callosum and corollary discharges
How can an understanding of changes in the callosum inform us about the neurobiology of schizophrenia? As the brain's largest white matter fibre bundle, if there are diffuse white matter changes in schizophrenia, callosal interhemispheric fibres -alongside long association tracts -are most likely to have both their structure and function disrupted. Consequent abnormalities in neural timing and synchrony between distal brain regions may thus produce the characteristic symptoms of schizophrenia. One particular function is highly dependent on accurate timing in these distal brain regions: corollary discharges, which are neural signals that are initiated in frontal cortical regions coincident with willed actions and fed posteriorly to sensory regions to suppress the sensory consequences of these actions, thereby allowing the brain to recognise these actions as 'self'-generated. 25 With subtle changes to white matter integrity, an introduced delay in this system may result in 'self'-generated phenomena being erroneously experienced as 'other': internal speech becomes external auditory hallucinations, internal images or thoughts are experienced as projected from an external source and somatic experiences as passivity phenomena. 26 Callosal microstructural abnormalities in schizophrenia are known to be accompanied by abnormal neural timing 27 and correlate with the severity of these psychotic symptoms. 28 Thus, alterations in the callosal macroand microstructure may be an index in people with schizophrenia of the severity of neural timing abnormalities, and thus the likelihood of the pathognomonic reality distortions in these patients whereby the distinction between 'self' and 'other' breaks down during episodes of psychosis. The Collinson et al 20 findings do not completely align with this hypothesis however, as changes would be expected to be detectable during both first-episode and established illness, as individuals are likely to experience these symptoms across illness stages. As the role of the callosum in schizophrenia pathology remains far from settled, the dissonance between the findings in the Collinson et al study and the corollary discharge hypothesis, and other models of schizophrenia that focus on the role of white matter, 18, 19 is likely to remain irresolvable for some time.
Conclusion
Magnetic resonance imaging in psychiatric illness provides rich data-sets that allow for a wide range of investigative approaches. The callosum is an attractive candidate for neuroimaging analysis as it is readily segmented, can be analysed in two as well as three dimensions, and has shape characteristics that can be measured manifold. Additionally, its degree of connectedness with disparate brain regions means that it can be used as an index for both white and grey matter change in the brain. However, the increasing variegation in analytical approaches to callosal structure may magnify, rather than simplify, the heterogeneity of complex mental disorders such as schizophrenia. Making future callosal studies meaningful in the context of schizophrenia requires us to move into more whole-of-brain, whole-of-illness approaches, which tie both structure and function together. This may allow us to determine whether the callosum in schizophrenia is the 'seat' of the illness, or merely its reflector.
